858 — Extrawell Pharmaceutical Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Extrawell Pharmaceutical Holdings, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	HKAS	HKAS	HKAS	HKAS	HKAS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	128	114	104	94.3	995
Net Total Accounts Receivable
Net Total Receivables	51.1	44.1	47.5	52.6	40.9
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	211	194	179	177	1,063
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	144	148	137	126	120
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,164	1,317	1,445	1,287	1,526
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	57.9	64.1	57	51.4	48.5
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	134	151	163	174	192
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,031	1,166	1,282	1,113	1,335
Total Liabilities & Shareholders' Equity	1,164	1,317	1,445	1,287	1,526
Total Common Shares Outstanding